Susceptibility of plasmenyl glycerophosphoethanolamine lipids containing arachidonate to oxidative degradation

被引:76
作者
Khaselev, N [1 ]
Murphy, RC [1 ]
机构
[1] Natl Jewish Med & Res Ctr, Dept Pediat, Div Basic Sci, Denver, CO 80206 USA
关键词
plasmalogens; molecular species; phospholipid oxidation; mass spectrometry; electrospray; antioxidant; arachidonate; oxidant stress; free radical;
D O I
10.1016/S0891-5849(98)00211-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Plasmenyl phospholipids (1-alk-1'-enyl-2-acyl-3-glycerophospholipids, plasmalogens) are a structurally unique class of lipids that contain an ct-unsaturated ether substituent at the sn-1 position of the glycerol backbone. Several studies have supported the hypothesis that plasmalogens may be antioxidant molecules that protect cells from oxidative stress. Because the molecular mechanisms responsible for the antioxidant properties of plasmenyl phospholipids are not fully understood, the oxidation of plasmalogens in natural mixtures of phospholipids was studied using electrospray tandem mass spectrometry. Glycerophosphoethanolamine (GPE) lipids from bovine brain were found to contain six major molecular species (16:0p/18:1-, 18:1p/18:1-, 18:0p/20:4-, 16:0p/20:4, 18:0a/20:4-, and 18:0a/22:6-GPE). Oxidation of GPE yielded lyse phospholipid products derived from plasmalogen species containing only monounsaturated sn-2 substituents and diacyl-GPE with oxidized polyunsaturated fatty acyl substituents at sn-2. The only plasmalogen species remaining intact following oxidation contained monounsaturated fatty acyl groups esterified at sn-2. The mechanism responsible for the rapid and specific destruction of plasmalogen GPE may likely involve unique reactivity imparted by a polyunsaturated fatty acyl group esterified at sn-2. This structural feature may play a central role determining the antioxidant properties ascribed to this class of phospholipids. (C) 1998 Elsevier Science Inc.
引用
收藏
页码:275 / 284
页数:10
相关论文
共 26 条
[1]   The role of oxidized lipoproteins in atherogenesis [J].
Berliner, JA ;
Heinecke, JW .
FREE RADICAL BIOLOGY AND MEDICINE, 1996, 20 (05) :707-727
[2]  
BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
[3]   Plasmalogen phospholipids in plasma lipoproteins of normolipidemic donors and patients with hypercholesterolemia treated by LDL apheresis [J].
Brautigam, C ;
Engelmann, B ;
Reiss, D ;
Reinhardt, U ;
Thiery, J ;
Richter, WO ;
Brosche, T .
ATHEROSCLEROSIS, 1996, 119 (01) :77-88
[4]   AMPHIPATHIC METABOLITES AND MEMBRANE DYSFUNCTION IN ISCHEMIC MYOCARDIUM [J].
CORR, PB ;
GROSS, RW ;
SOBEL, BE .
CIRCULATION RESEARCH, 1984, 55 (02) :135-154
[5]   PLASMALOGEN PHOSPHOLIPIDS AS POTENTIAL PROTECTORS AGAINST LIPID-PEROXIDATION OF LOW-DENSITY LIPOPROTEINS [J].
ENGELMANN, B ;
BRAUTIGAM, C ;
THIERY, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 204 (03) :1235-1242
[6]  
GUTTERIDGE JMC, 1995, CLIN CHEM, V41, P1819
[7]   Analysis of stable oxidized molecular species of glycerophospholipids following treatment of red blood cell ghosts with t-butylhydroperoxide [J].
Hall, LM ;
Murphy, RC .
ANALYTICAL BIOCHEMISTRY, 1998, 258 (02) :184-194
[8]  
HALLIWELL B, 1989, FREE RADICAL BIO MED, V2, P188
[9]  
Horrocks LA., 1972, ETHER LIPIDS CHEM BI, P177, DOI DOI 10.1016/B978-0-12-654150-2.50016-6
[10]   CONTRIBUTION OF PROSTAGLANDINS TO REPERFUSION-INDUCED VENTRICULAR FAILURE IN ISOLATED RAT HEARTS [J].
KARMAZYN, M .
AMERICAN JOURNAL OF PHYSIOLOGY, 1986, 251 (01) :H133-H140